Frontocingulate dysfunction in depression: Toward biomarkers of treatment response

734Citations
Citations of this article
809Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Increased rostral anterior cingulate cortex (rACC) activity has emerged as a promising predictor of treatment response in depression, but neither the reliability of this relationship nor the mechanisms supporting it have been thoroughly investigated. This review takes a three-pronged approach to these issues. First, I present a meta-analysis demonstrating that the relationship between resting rACC activity and treatment response is robust. Second, I propose that the rACC plays a key role in treatment outcome because of its 'hub' position in the default network. Specifically, I hypothesize that elevated resting rACC activity confers better treatment outcomes by fostering adaptive self-referential processing and by helping to recalibrate relationships between the default network and a 'task-positive network' that comprises dorsolateral prefrontal and dorsal cingulate regions implicated in cognitive control. Third, I support this hypothesis by reviewing neuropsychological, electrophysiological, and neuroimaging data on frontocingulate dysfunction in depression. The review ends with a discussion of the limitations of current work and future directions. © 2011 Nature Publishing Group All rights reserved.

Cite

CITATION STYLE

APA

Pizzagalli, D. A. (2011, January). Frontocingulate dysfunction in depression: Toward biomarkers of treatment response. Neuropsychopharmacology. https://doi.org/10.1038/npp.2010.166

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free